Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yangxueqingnao pill
- Development stage
- Unknown
- Lead developer
- Tasly Pharmaceutical
- Administration
- Oral
01
Overview
Yangxueqingnao pill is a Traditional Chinese Medicine (TCM) formula developed by Tasly Pharmaceutical Group, widely used in China for the treatment of chronic cerebral circulation insufficiency, tension-type headaches, and migraines. The formula consists of 11 herbal components, including *Angelica sinensis*, *Ligusticum chuanxiong*, and *Uncaria rhynchophylla*. Its therapeutic effects are attributed to its ability to improve cerebral blood flow, inhibit platelet aggregation, and provide neuroprotection by reducing oxidative stress and inflammatory responses. Clinical research, including studies sponsored by Beijing Hospital, is currently evaluating its efficacy in improving cognitive function in patients with vascular cognitive impairment without dementia (VCIND).
- Brand names
- Yangxueqingnao
- Other names
- Yangxue Qingnao WanYangxue Qingnao PillYangxue Qingnao Dropping Pill
02
Targets
DRD (Dopamine receptors)CaV (Voltage-gated calcium channel protein complex)
Beyond the preview
Go deeper on yangxueqingnao pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yangxueqingnao pill.